HIGHLIGHTS
- who: Shoichiro Tange from the Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, S, Chuou2011ku, Sapporo, u20118556, Japan have published the research: MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway, in the Journal: (JOURNAL)
- what: The authors report that MYEOV expression is significantly upregulated at the transcriptional level in pancreatic cancer tissues and that the expression of MYEOV is a prognostic indicator that correlates with shorter disease-specific survival independent of lymph . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.